Abiopharma

🔍 Kurtenbach Matthew John (Executive)

Company: DAKTRONICS INC /SD/ (DAKT)

Report Date: 2026-08-23

Detailed Transactions and Holdings:

• Acquired 500 shares of Common Stock (Direct)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 339,005.70 | transaction_form_type: 4 | Footnotes: F1
• Sold 121 shares of Common Stock at $19.0 per share (Direct)
  Date: 2026-08-23 | Code: F | equity_swap_involved: 0 | shares_owned_after: 338,884.70 | transaction_form_type: 4 | Footnotes: F2, F2
• Acquired 500 shares of Common Stock (Direct)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 339,384.70 | transaction_form_type: 4 | Footnotes: F1
• Sold 121 shares of Common Stock at $19.0 per share (Direct)
  Date: 2026-08-23 | Code: F | equity_swap_involved: 0 | shares_owned_after: 339,263.70 | transaction_form_type: 4 | Footnotes: F2, F2
• Acquired 246 shares of Common Stock (Direct)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 339,509.70 | transaction_form_type: 4 | Footnotes: F1
• Sold 59 shares of Common Stock at $19.0 per share (Direct)
  Date: 2026-08-23 | Code: F | equity_swap_involved: 0 | shares_owned_after: 339,450.70 | transaction_form_type: 4 | Footnotes: F2, F2
• Acquired 454 shares of Common Stock (Direct)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 339,904.70 | transaction_form_type: 4 | Footnotes: F1
• Sold 110 shares of Common Stock at $19.0 per share (Direct)
  Date: 2026-08-23 | Code: F | equity_swap_involved: 0 | shares_owned_after: 339,794.70 | transaction_form_type: 4 | Footnotes: F2, F2
• Acquired 2,098 shares of Common Stock (Direct)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 341,892.70 | transaction_form_type: 4 | Footnotes: F1
• Sold 510 shares of Common Stock at $19.0 per share (Direct)
  Date: 2026-08-23 | Code: F | equity_swap_involved: 0 | shares_owned_after: 341,382.70 | transaction_form_type: 4 | Footnotes: F2, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-23 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 5,000.00 | Footnotes: F3, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-23 | Code: H | nature_of_ownership: As custodian for UTMA Accounts for minors | shares_owned_after: 21,000.00 | Footnotes: F3, F3
• Sold 500 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F6, F6
• Sold 500 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 500.00 | transaction_form_type: 4 | Footnotes: F1, F7, F7
• Sold 246 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 492.00 | transaction_form_type: 4 | Footnotes: F1, F8, F8
• Sold 454 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,362.00 | transaction_form_type: 4 | Footnotes: F1, F9, F9
• Sold 2,098 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,293.00 | transaction_form_type: 4 | Footnotes: F1, F10, F10

Footnotes:

• F1: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Daktronics, Inc. common stock.
• F2: Represents the number of shares deemed withheld to satisfy tax withholding obligations upon vesting of RSUs previously granted to the Reporting Person.
• F3: For purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), the Reporting Person disclaims beneficial ownership of any securities reported in this filing, except to the extent of his pecuniary interest therein, if any, and this Amendment shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
• F4: As a trustee of a trust formed for the benefit of a child of the Reporting Person (the "Trust"), the Reporting Person may be deemed to exercise voting and investment power over the shares of common stock of Daktronics, Inc. ("Common Stock") held by the Trust.
• F5: Represents securities held in 3 separate custodial accounts under the Uniform Transfers to Minors Act (the "UTMA"). The Reporting Person is the custodian of the UTMA accounts held for the benefit of his children.
• F6: Represents RSUs granted on 9/2/2021 under the Daktronics, Inc. 2020 Stock Incentive Plan. The RSUs vest in five equal installments beginning August 23, 2022, subject to certain vesting, forfeiture, and terminative provisions.
• F7: Represents RSUs granted on 9/8/2022 under the Daktronics, Inc. 2020 Stock Incentive Plan. The RSUs vest in five equal installments beginning August 23, 2023, subject to certain vesting, forfeiture, and terminative provisions.
• F8: Represents RSUs granted on 9/11/2023 under the Daktronics, Inc. 2020 Stock Incentive Plan. The RSUs vest in five equal installments beginning August 23, 2024, subject to certain vesting, forfeiture, and terminative provisions.
• F9: Represents RSUs granted on 9/9/2024 under the Daktronics, Inc. 2020 Stock Incentive Plan. The RSUs vest in five equal installments beginning August 23, 2025, subject to certain vesting, forfeiture, and terminative provisions.
• F10: Represents RSUs granted on 7/28/2025 under the Daktronics, Inc. 2020 Stock Incentive Plan. The RSUs vest in four equal installments beginning August 23, 2026, subject to certain vesting, forfeiture, and terminative provisions.